Cryptocurrency & Digital Assets

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

TUDOR answers enthusiast calls with a new 36mm Ranger and a striking 'Dune white' dial, blending vintage appeal with modern technical prowess.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Canada's space pioneer MDA is moving into land, sea, and air defence with a new subsidiary, aiming to capture billions in spending and boost national security.

With two strategic hires from TriNetX and Canon Medical, Avandra signals an aggressive push to unlock siloed medical imaging data for research and AI.

Sebring Resorts is redefining luxury with a motorsports-themed community where collectors and racers can live alongside the iconic Florida raceway.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

Israeli cannabis firm InterCure posts 11% revenue growth in 2025, showing resilience after conflict and making its first major push into the booming German market.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Hydro-Québec plans to double electricity rates for large data centers, a strategic move to manage soaring demand and revalue its clean energy resources.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

The firm's new SBIC fund leverages a key government partnership to inject vital capital into the U.S. lower middle-market, a critical engine for the economy.

A new partnership turns agricultural waste into high-value carbon credits, boosting soil health and creating jobs in West Africa's cashew heartland.

ICANN's 2026 domain expansion offers Turkish firms a rare chance to claim new digital real estate. But is the opportunity worth the significant cost?

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

BPCL's major bio-gas agreements in Uttar Pradesh advance national green energy goals and boost the rural economy, but face a complex road ahead.